Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 92 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

13 trials in Phase 3/4

Results Transparency

0%

0 of 26 completed trials have results

Key Signals

14 recruiting

Enrollment Performance

Analytics

N/A
27(48.2%)
Phase 2
12(21.4%)
Phase 4
7(12.5%)
Phase 3
6(10.7%)
Phase 1
4(7.1%)
56Total
N/A(27)
Phase 2(12)
Phase 4(7)
Phase 3(6)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (92)

Showing 20 of 92 trials
NCT07727889Phase 2Active Not Recruiting

A 24-Week Real-World Study of Upadacitinib in Moderate-to-Severe Hidradenitis Suppurativa

Role: lead

NCT07596290Phase 2Not Yet Recruiting

Yang et al. Anti-PD-1/CTLA-4 Dual Immunotherapy for LARC

Role: collaborator

NCT07634276Not ApplicableNot Yet Recruiting

Tooth and Bone-borne Cutting/Repositioning Guide and Patient-specific Implant(PSI)

Role: lead

NCT06458205Not ApplicableCompleted

Impact of Multi-Component Interventions on High-Risk COPD Smokers

Role: lead

NCT06458218Not ApplicableCompleted

Impact of Multi-component Interventions on Populations With Mental Health Symptoms and High-risk COPD

Role: lead

NCT06457009Not ApplicableCompleted

Impact of Multi-Component Intervention on Suspected Asthma Population

Role: lead

NCT07622758Completed

Retrospective Study on the Application of Tooth-bone Dual-support Osteotomy/Location Plate in "Surgery-first" Orthognathic Treatment

Role: lead

NCT06456996Not ApplicableCompleted

Impact of Multi-Component Interventions on High Risk COPD Population

Role: lead

NCT05146193Recruiting

AI-Powered Scoliosis Auto-Analysis System Multicenter Development and Validations

Role: collaborator

NCT07535489Phase 2Not Yet Recruiting

Efficacy and Safety of IPG11406 in Moderately to Severely Active Ulcerative Colitis (Phase 2)

Role: collaborator

NCT06145308Phase 2Recruiting

Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing

Role: lead

NCT07481695Completed

Retrospective Follow-up Study on Lower Eyelid Melanin and Wrinkles After Blepharoplasty for Lower Eyelid Bags

Role: lead

NCT07426107Not Yet Recruiting

Development and Prospective Validation of an AI Model for Prognosis in ITP Patients Undergoing Coronary Revascularization

Role: collaborator

NCT07344987Not ApplicableNot Yet Recruiting

Effect of Indoor Air Quality Improvement on Health in Patients With Interstitial Lung Disease

Role: lead

NCT00289380Recruiting

Nutrition Support on Outcomes and Cost-effectiveness for Patients at Risk

Role: lead

NCT05917418Not ApplicableNot Yet Recruiting

Nutritional Support on Outcomes and Cost-effectiveness for Patients at Risk

Role: lead

NCT07312318Recruiting

AI-Driven Dynamic Prediction of Non-Target Lesion Progression After PCI: A Chinese Multicenter Cohort Study

Role: collaborator

NCT07305909Completed

Two- and Three-Dimensional Quantification of Facial Symmetry After Fat Grafting and Free Flap Reconstruction in Hemifacial Atrophy

Role: lead

NCT07305766Not ApplicableCompleted

Construction and Preliminary Application of Evidence-Based Nursing Protocol for Oral Mucositis Related to Tumor Therapy

Role: lead

NCT05465343Phase 2Completed

Furmonertinib in EGFR-Mutant NSCLC With Brain Metastases (iFORCE)

Role: lead